Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation

por Sigl, M, Spoerl, S, Schnittger, S, Meissner, J, Rummelt, C, Peschel, C, Duyster, J, Ho, A D, von Bubnoff, N
Publicado 2013

P1232: PRINCIPLES OF PRECISION ONCOLOGY IN PRIMARY REFRACTORY HIGH-GRADE B-CELL LYMPHOMA WITH MYC-, BCL2 AND/OR BCL6 REARRANGEMENTS (HGBL-DH/TH)

por Witte, H., Faehnrich, A., Riedl, J., Kuenstner, A., Ketzer, J., von Bubnoff, N., Merz, H., Busch, H., Feller, A., Gebauer, N.
Publicado 2022

P1233: PRIMARY REFRACTORY PLASMABLASTIC LYMPHOMA: A PRECISION ONCOLOGY APPROACH

por Witte, H., Fähnrich, A., Riedl, J., Kuenstner, A., Hertel, N., von Bubnoff, N., Merz, H., Busch, H., Feller, A., Gebauer, N.
Publicado 2022

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA

por Stegelmann, F., Jahn, E., Koschmieder, S., Heidel, F., Hochhaus, A., Hebart, H., Isfort, S., Reiter, A., Bangerter, M., Waller, C. F., Wolleschak, D., Scheid, C., Göthert, J., Schafhausen, P., Kindler, T., Radsak, M. P., Gattermann, N., Möhle, R., von Bubnoff, N., Schrade, A., Brümmendorf, T., Döhner, H., Griesshammer, M., Döhner, K.
Publicado 2022